Clinical Trial Update: Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing insulin to insulin glargine in adults with Type 2 diabetes has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED